⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FTRE News
Fortrea Holdings Inc. Common Stock
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Shareholders to Reach Out
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
FTRE
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
FTRE
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
FTRE
Levelpath Named a Representative Vendor in 2026 Gartner® Market Guide for Sourcing Applications
businesswire.com
AMGN
CPNG
FTRE
GATX
SIRI
SSM
WU
QS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Connect
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Stockholders to Inquire about Securities Investigation
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
FTRE
Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
globenewswire.com
FTRE
ICLR
LH
TMO
VEEV